ESMO Clinical Practice Guidelines: Haematological Malignancies

The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.

Latest enhanced and revised set of guidelines

ESMO has Clinical Practice Guidelines on the following Haematological Malignancies: Acute lymphoblastic leukaemia, Philadelphia chromosome-negative chronic myeloproliferative neoplasms, Hairy cell leukaemia, Peripheral T-cell lymphomas, Myelodysplastic syndromes, Waldenström's macroglobulinaemia, Multiple myeloma, Acute myeloblastic leukaemia in adult patients, Chronic lymphocytic leukaemia, Chronic myeloid leukemia, Hodgkin's lymphoma, Mantle cell lymphoma, Diffuse large B-cell lymphoma, Gastric marginal zone lymphoma of MALT type, Primary cutaneous lymphoma, newly diagnosed and relapsed Follicular lymphoma and extranodal diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma.
They include information on incidence, diagnosis, staging and risk assessment, treatment, response evaluation and follow-up.

Haematologic malignancies

Waldenstrom’s Macroglobulinaemia: ESMO Clinical Practice Guidelines

Published in 2013 – Ann Oncol 2013; 24 (Suppl 6): vi125-vi132.

Authors: C. Buske, V. Leblond, M. Dimopoulos, E. Kimby, U. Jäger, M. Dreyling

view detailsof Waldenstrom’s Macroglobulinaemia: ESMO Clinical Practice Guidelines

Haematologic malignancies

Gastric Marginal Zone Lymphoma of MALT Type: ESMO Clinical Practice Guidelines

Published in 2013 – Ann Oncol 2013; 24 (Suppl 6): vi144-vi148.

Authors: E. Zucca, C. Copie-Bergman, U. Ricardi, C. Thieblemont, M. Raderer, M. Ladetto

view detailsof Gastric Marginal Zone Lymphoma of MALT Type: ESMO Clinical Practice Guidelines

Haematologic malignancies

ESMO Consensus Guidelines: Marginal Zone Lymphoma, Mantle Cell Lymphoma, Peripheral T-cell Lymphoma

Published in 2013 - Ann Oncol (2013) 24 (4): 857-877.
Authors: M. Dreyling, C. Thieblemont, A. Gallamini, L. Arcaini, E. Campo, O. Hermine, J. C. Kluin-Nelemans, M. Ladetto, S. Le Gouill, E. Iannitto, S. Pileri, J. Rodriguez, N. Schmitz, A. Wotherspoon, P. Zinzani, E. Zucca

view detailsof ESMO Consensus Guidelines: Marginal Zone Lymphoma, Mantle Cell Lymphoma, Peripheral T-cell Lymphoma

Haematologic malignancies

ESMO Consensus Guidelines: Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma (FL) and Chronic Lymphocytic Leukemia (CLL)

Published in 2013 - Ann Oncol (2013) 24 (3): 561-576.
Authors: M. Ghielmini, U. Vitolo, E. Kimby, S. Montoto, J. Walewski, M. Pfreundschuh, M. Federico, P. Hoskin, C. McNamara, F. Caligaris-Cappio, S. Stilgenbauer, R. Marcus, M. Trneny, P. Dreger, E. Montserrat, M. Dreyling

view detailsof ESMO Consensus Guidelines: Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma (FL) and Chronic Lymphocytic Leukemia (CLL)

Haematologic malignancies

Chronic Myeloid Leukemia: ESMO Clinical Practice Guidelines

Published in 2012 – Ann Oncol 2012; 23 (Suppl 7): vii72-vii77.

Authors: M. Baccarani, S. Pileri, J.-L. Steegmann, M. Muller, S. Soverini, M. Dreyling

view detailsof Chronic Myeloid Leukemia: ESMO Clinical Practice Guidelines